SEARCH
MDx-Chex for BC-GP is a patient-like full process controls designed to validate the entire analytical process of the Luminex VERIGENE® BC-GP Panel, including automated nucleic acid extraction, DNA purification, hybridization of target DNA to the microarray, hybridization of gold nanoparticles to target DNA and silver staining of hybridized probes.
Patient-like matrix of inactivated microorganisms, blood cells and culture media components
Can be directly used on the Luminex VERIGENE system
Complete coverage of all BC-GP Panel targets in a single vial
Negative controls contain only blood cells and culture media components for a true patient-like negative control
Challenges and verifies the entire analytical process of the Luminex VERIGENE BC-GP Panel
Reduces preanalytical variables such as pipetting errors and cross-contamination
Easy to use — simply pipette like a patient sample
| Description | Item Number |
|---|---|
| MDx-Chex for BC-GP – 5 Tubes Positive Control, 5 Tubes Negative Control | 250079 |
MDx-Chex for BC-GP is a patient-like full process control designed to validate the entire analytical process of the Luminex VERIGENE BC-GP Panel for sepsis testing. This control contains intact, inactivated microorganisms suspended in a matrix of stabilized red blood cells, white blood cells and blood culture media components, allowing them to behave like positive patient blood culture samples.
MDx-Chex for BC-GP provides complete coverage of all targets detected by the Luminex VERIGENE BC-GP Panel (gram-positive organisms and associated resistance markers). MDx-Chex for BC-GN provides complete coverage of all targets detected by the Luminex VERIGENE BC-GN Panel (gram-negative organisms and associated resistance markers). Each control is designed for its specific panel, and laboratories typically need both products to ensure comprehensive quality control across all sepsis testing.
MDx-Chex for BC-GP challenges and verifies every step of the Luminex VERIGENE workflow, including automated nucleic acid extraction, DNA purification, hybridization of target DNA to the microarray, hybridization of gold nanoparticles to target DNA and silver staining of hybridized probes. This comprehensive validation helps detect instrument or assay failures before they impact patient results.
Yes, MDx-Chex for BC-GP can be directly pipetted onto the Luminex VERIGENE system just like a patient sample. The control reduces preanalytical variables such as pipetting errors and cross-contamination because it can be mixed and handled using the same workflow as actual patient blood culture samples.
Yes, MDx-Chex for BC-GP has FDA Class II clearance for use with the Luminex VERIGENE BC-GP Panel. This clearance provides assurance of quality and performance for laboratories seeking regulatory compliance and accreditation.
No, MDx-Chex for BC-GP can be stored at room temperature, which simplifies storage requirements and provides greater flexibility in laboratory inventory management.
